Real-time Estimate
Tradegate
12:38:23 25/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
4.251
EUR
|
-1.07%
|
|
+3.64%
|
+5.58%
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,042
|
2,156
|
-
|
-
|
Enterprise Value (EV)
1 |
2,042
|
2,156
|
2,156
|
2,156
|
P/E ratio
|
12.7
x
|
12.7
x
|
13.8
x
|
13.7
x
|
Yield
|
8.11%
|
7.73%
|
7.81%
|
7.56%
|
Capitalization / Revenue
|
60,40,558
x
|
-
|
-
|
-
|
EV / Revenue
|
60,40,558
x
|
-
|
-
|
-
|
EV / EBITDA
|
1,11,54,084
x
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
Price to Book
|
1.28
x
|
1.34
x
|
1.31
x
|
1.44
x
|
Nbr of stocks (in thousands)
|
5,01,797
|
5,01,797
|
-
|
-
|
Reference price
2 |
4.070
|
4.297
|
4.297
|
4.297
|
Announcement Date
|
13/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net sales
|
338.1
|
-
|
-
|
-
|
EBITDA
|
183.1
|
-
|
-
|
-
|
EBIT
1 |
178.3
|
199.9
|
189
|
179.5
|
Operating Margin
|
52.74%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
210.4
|
211.7
|
194.1
|
194.8
|
Net income
1 |
160.7
|
167.2
|
152
|
150.2
|
Net margin
|
47.53%
|
-
|
-
|
-
|
EPS
2 |
0.3200
|
0.3376
|
0.3120
|
0.3139
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.3300
|
0.3322
|
0.3357
|
0.3247
|
Announcement Date
|
13/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
|
-
|
-
|
-
|
-
|
167.6
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
-
|
51.3
|
-
|
51.53
|
50.89
|
50.62
|
Operating Margin
|
-
|
-
|
-
|
-
|
30.61%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
83.9
|
46.3
|
130.2
|
46.9
|
51.1
|
-
|
-
|
Net income
1 |
23.6
|
63.3
|
68.2
|
29.2
|
97.4
|
37.8
|
40.9
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
58.11%
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
0.3000
|
-
|
0.0600
|
0.0200
|
0.0800
|
0.0800
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/05/23
|
16/08/23
|
08/11/23
|
13/02/24
|
13/02/24
|
08/05/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
9.8%
|
10.6%
|
10.5%
|
10.1%
|
ROA (Net income/ Total Assets)
|
1.03%
|
1.05%
|
0.96%
|
0.84%
|
Assets
1 |
15,596
|
15,935
|
15,812
|
17,833
|
Book Value Per Share
2 |
3.190
|
3.200
|
3.280
|
2.990
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
13/02/24
|
-
|
-
|
-
|
Last Close Price
4.297
EUR Average target price
4
EUR Spread / Average Target -6.91% Consensus |
1st Jan change
|
Capi.
|
---|
| +5.58% | 231.33Cr | | +4.98% | 7.3TCr | | +9.61% | 5.14TCr | | +9.06% | 5.13TCr | | +22.23% | 4.69TCr | | +14.90% | 4.28TCr | | +23.53% | 3.92TCr | | +19.81% | 3.42TCr | | -2.40% | 2.85TCr | | +31.80% | 2.73TCr |
Other Life & Health Insurance
|